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PRelationship Between C-Reactive
Protein Levels and Regional Left
Ventricular Function in Asymptomatic Individuals
The Multi-Ethnic Study of Atherosclerosis
Boaz D. Rosen, MD,* Mary Cushman, MD,† Khurram Nasir, MD, MPH,*
David A. Bluemke, MD, PHD,‡ Thor Edvardsen, MD, PHD,* Verônica Fernandes, MD, PHD,*
Shenghan Lai, MD, PHD,§ Russell P. Tracy, PHD,† João A. C. Lima, MD, FACC*‡
Baltimore, Maryland; and Burlington, Vermont
Objectives This study sought to investigate the relationship between C-reactive protein (CRP) and regional left ventricular
(LV) function in asymptomatic individuals without a history of cardiovascular disease.
Background C-reactive protein is associated with an increased risk for developing cardiovascular disease. However, the rela-
tionship between CRP and subclinical LV dysfunction has not been evaluated in asymptomatic individuals.
Methods Regional myocardial function was analyzed as peak systolic circumferential shortening strain (Ecc) using the
harmonic-phase method by tagged magnetic resonance imaging in 1,164 individuals without symptomatic cardiovas-
cular disease from the MESA (Multi-Ethnic Study of Atherosclerosis) trial (age 66.4 9.6 years old). Regions were
defined by coronary territories: left anterior descending artery (LAD), left circumflex artery (LCX), and right coronary
artery (RCA). The relationship between log-CRP concentration and Ecc was studied by multivariable linear regression
after adjustment for demographic characteristics, risk factors, and therapy (including hormone replacement therapy).
Results For each region, associations differed by gender with no association of CRP and regional LV function among
women. In men, after adjustment, higher log-CRP was significantly associated with lower (absolute) Ecc in the
LAD and RCA regions (regression coefficient 0.37 per unit higher log-CRP [95% confidence interval [CI] 0.08 to
0.65] and 0.31 [95% CI 0.02 to 0.59], respectively) and peak systolic Ecc overall (regression coefficient 0.32
[95% CI 0.05 to 0.58]). In the LCX region, the association was weaker (p  0.06).
Conclusions Among individuals without evident heart failure or other cardiovascular disorders, higher CRP was associated
with lower systolic myocardial function in all regions in men but not in women. These findings support the role of
inflammation and atherosclerosis in incipient myocardial dysfunction. (Multi-Ethnic Study of Atherosclerosis;
http://clinicaltrials.gov/ct/show/NCT00005487). (J Am Coll Cardiol 2007;49:594–600) © 2007 by the
American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.09.040a
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fnflammation plays an important role in the development
nd progression of atherosclerosis and congestive heart
ailure (CHF) (1). The inflammatory process contributes to
he formation of early atherosclerotic plaques in the form of
ipid-laden macrophages and induces plaque weakening and
upture leading to acute coronary syndromes and sudden
eath (2,3). Furthermore, many circulating markers of
nflammation, particularly C-reactive protein (CRP), are
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Coronary artery disease (CAD) is the major cause of left
entricular (LV) dysfunction and CHF (10). In this regard,
raditional risk factors for CAD as well as CRP are
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February 6, 2007:594–600 Association Between CRP and LV Functionardiovascular events, CRP was most strongly associated
ith future CHF (11).
Because CAD is regional, it is intuitive to expect that the
rogressive LV dysfunctional process that underlies CHF
ould commence as a regional process that eventually
esults in global dysfunction and failure. In this regard,
lthough most studies relating inflammatory markers to the
evelopment of CAD used clinical events as end points,
one have yet examined the relationship between systemic
arkers of inflammation and regional LV dysfunction in
symptomatic individuals.
The goal of this study was to investigate the association
etween CRP and the presence and extent of regional LV
ysfunction in asymptomatic participants of the MESA
Multi-Ethnic Study of Atherosclerosis) trial. Our hypoth-
sis was that higher levels of CRP would be related to
egional LV dysfunction involving 1 or more coronary
erritories independently of traditional risk factors.
ethods
he MESA trial is a prospective study designed to evaluate
echanisms underlying the development and progression of
ubclinical cardiovascular disease in asymptomatic individ-
als (12). There were 6,814 men and women, 45 to 85 years
f age, from 4 ethnicities (non-Hispanic white, African
merican, Hispanic, and Chinese) enrolled at 6 field
enters (Winston Salem, North Carolina; New York, New
ork; Baltimore, Maryland; Minneapolis, Minnesota; Chi-
ago, Illinois; and Los Angeles, California). At entry, all
articipants underwent extensive evaluation including clin-
cal history, physical examination, and laboratory tests
ncluding fasting glucose, lipid panel, and CRP. The
ESA protocol was approved by the institutional review
oards in all participating centers. Informed consent was
btained from all study participants.
agged MRI studies. In an ancillary study of MESA,
,184 participants randomly selected underwent tagged
agnetic resonance imaging (MRI) studies at enrollment
from September 2001 to September 2002) in 6 centers.
mages were acquired by whole-body scanners (1.5 CVi,
eneral Electric Medical Systems, Waukesha, Wisconsin,
nd Sonata/Symphony Siemens Medical Solutions, Erlan-
en, Germany) using electrocardiograph-triggered seg-
ented k-space fast spoiled gradient-echo pulse sequence
uring breath holds. After completing the standard proto-
ol, 3 tagged short-axis slices (base to apex) were obtained.
arallel striped tags were prescribed in 2 orthogonal
rientations (0° and 90°) using electrocardiograph-triggered
ast gradient echo sequence with spatial modulation of
agnetization.
Parameters for tagged images were: field of view 40 cm;
lice thickness 7 to 8 mm; repetition time 6 ms; echo time
.0 ms; flip angle 10° to 12°; phase encoding views 128 with
phase encoding views per segment; temporal resolution 40
s; tag spacing 7 mm. bThe LV mass was determined
or each participant using dedi-
ated commercially available
oftware (MASS, version 4.2,
edis, Leiden, the Netherlands)
t end diastole.
train analysis. Short-axis
agged slices were analyzed using
ARP (harmonic phase). The
ARP program (Diagnosoft,
alo Alto, California) enables a
ast determination of myocardial
train (13–15). In the present
tudy, peak systolic midwall cir-
umferential strain (Ecc) was de-
ermined in 12 segments in 3
lices. By convention, systolic
cc is normally negative because
f circumferential shortening, and
educed (absolute) Ecc values re-
ect decreased regional function (for example, Ecc  12%
eflects lower regional function when compared with Ecc 
18%). Regional strains were analyzed according to coronary
erfusion areas (left anterior descending artery [LAD], left
ircumflex artery [LCX], and right coronary artery [RCA]
erritories). Assignment to coronary territories was done ac-
ording to published standards (16). Peak global systolic strain
as defined as the peak midwall Ecc averaged across all
idwall segments.
isk factors and CRP concentrations. Hypertension was
efined as diastolic blood pressure 90 mm Hg, systolic
lood pressure 140 mm Hg, or receiving treatment for
ypertension. High-normal diastolic blood pressure was
efined as90 and85 mm Hg. Dyslipidemia was defined
s total cholesterol 240 mg/dl, low-density lipoprotein
holesterol 160 mg/dl, triglycerides 150 mg/dl, high-
ensity lipoprotein cholesterol 45 mg/dl, or receiving
reatment for hyperlipidemia. Diabetic individuals were de-
ned as either having fasting plasma glucose 126 mg/dl or
eceiving treatment for diabetes. Impaired fasting glucose was
efined as glucose100 and126 mg/dl. Smoking status was
efined as current smoking, former smoking, or never smoked.
C-reactive protein was measured using the BNII nephe-
ometer (N High-Sensitivity CRP; Dade Behring, Deer-
eld, Illinois). Analytical intra-assay coefficients of variation
CVs) range from 2.3% to 4.4%, and interassay CVs range
rom 2.1% to 5.7%.
tatistical analysis. The distribution of CRP was skewed;
herefore, log-transformation was performed. Data for CRP
re presented as median and interquartile range (IQR). All
nalyses were done using STATA-8 software (Stata Corp.,
ollege Station, Texas). The CRP levels in different sub-
roups were compared using the Mann-Whitney U and
ruskal-Wallis tests.
Linear regression was used to study the relationship
Abbreviations
and Acronyms
CAD  coronary artery
disease
CHF  congestive heart
failure
CI  confidence interval
CRP  C-reactive protein
Ecc  circumferential strain
IQR  interquartile range
LAD  left anterior
descending artery
LCX  left circumflex artery
LV  left ventricular
MESA  Multi-Ethnic Study
of Atherosclerosis
RCA  right coronary arteryetween log-CRP and regional Ecc. To test whether the
r
f
w
t
r
w
t
L
m
i
E
e
t
b
r
f
M
a
h
t
d
M
t
I
a
c
i
d
R
R
T
596 Rosen et al. JACC Vol. 49, No. 5, 2007
Association Between CRP and LV Function February 6, 2007:594–600elationship between regional LV function and CRP dif-
ered by gender, age, ethnicity, or central obesity indexed by
aist circumference, interaction terms between CRP and
hese factors were included in the initial multivariable
egression models. Only the gender  log-CRP interaction
as significant in most of the regions (p values for interac-
ions were 0.1, 0.07, 0.03, and 0.04 for Ecc in the LAD,
CX, RCA, and peak global Ecc, respectively). Therefore,
en and women were analyzed separately.
Multivariable linear regression was used to study the
ndependence of the association of log-CRP with regional
cc. Variables included as potential confounders were age,
thnicity, waist circumference, hypertension, total choles-
erol, treatment for hypertension or high cholesterol, dia-
etes mellitus, and smoking status. In women, hormone
eplacement therapy use was also included (current use vs.
ormer and never use). Regression was performed in 3 steps.
Risk Factor Profile of the Study Participants
Table 1 Risk Factor Profile of the Study Par
Men
Characteristics
Number 635 (54)
Ethnicity
Caucasian 191 (30)
Asian 70 (11)
African American 169 (27)
Hispanic 205 (32)
Age (yrs) 66  10
Body mass index (kg/m2) 27.2  3.
Risk factors
Blood pressure
SBP (mm Hg) 128  19
DBP (mm Hg) 75  9
Hypertensive 265 (41.7)
Treatment for HTN 208 (32.8)
Lipids
Total cholesterol (mg/dl) 186  33
LDL cholesterol (mg/dl) 116  30
HDL cholesterol (mg/dl) 46  12
Triglycerides (mg/dl) 130  84
Dyslipidemia 248 (39)
Treatment for hyperlipidemia 118 (19)
Smoking
Never smoked 268 (42)
Former smoker 282 (45)
Current smoker 82 (13)
Glucose
Plasma glucose (mg/dl) 110  31
Diabetes mellitus 76 (12)
CRP (mg/l)† 1.3 (0.7–3
LV mass (g) 166  39
Percentages are shown in parentheses. Continuous variables are prese
for continuous variables and chi-square for categorical variables; †b
ranges are presented. Mann-Whitney U test was used to compare CRP
liter, multiply by 0.0259; to convert values for glucose to millimoles pe
liter, multiply by 0.0113.CRP  C-reactive protein; DBP  diastolic blood pressure; HDL  high-den
LV mass  left ventricular mass; SBP  systolic blood pressure.odel I (demographic parameters) included age, ethnicity,
nd waist circumference. Model II (risk factors): history of
ypertension, antihypertensive medication, cholesterol, an-
ihyperlipidemic medication, smoking status, and history of
iabetes mellitus in addition to the variables included in
odel I. In women, adjustment for hormone replacement
herapy status (current users vs. nonusers) was added. Model
II included demographic parameters (I), risk factors (II),
nd LV mass or coronary artery calcium scores in the
orresponding arteries (e.g., coronary artery calcium scores
n the LAD for Ecc LAD). Statistical significance was
efined as p  0.05.
esults
isk factor profiles of the study participants are shown in
able 1. A total of 1,184 individuals underwent tagged
nts
Women
Gender Difference
(p Value*)
549 (46)
173 (30)
65 (12)
153 (28)
158 (29) 0.6
67  9 0.6
28.3  5.2 0.001
130  23 0.1
69  11 0.001
261 (47.5) 0.05
190 (34.6) 0.5
202  36 0.001
120  30 0.02
56  15 0.001
132  77 0.6
197 (36) 0.3
116 (21) 0.3
338 (62)
159 (29)
48 (9) 0.001
103  21 0.001
58 (11) 0.4
2.6 (1.2–5.7) 0.001
122  27 0.001
s mean  standard deviation. *The p values were calculated by t test
of the skewed distribution of CRP, median values and interquartile
To convert values for total, HDL, and LDL cholesterol to millimoles per
ultiply by 0.0555; to convert values for triglycerides to millimoles perticipa
9
.0)
nted a
ecause
levels.
r liter, msity lipoprotein; HTN  hypertension; LDL  low-density lipoprotein;
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February 6, 2007:594–600 Association Between CRP and LV FunctionRI, of whom there were 1,164 (98.3%) participants with
vailable CRP data. Their mean age was 66.4  10 years.
ompared with the overall MESA trial cohort (total 6,814
articipants), the studied subgroup included a higher per-
entage of men (54% vs. 47%, p  0.001), a greater number
f Caucasians, and a smaller number of Hispanic individuals
p  0.001 for both ethnic groups). However, the distribu-
ions of risk factors and CRP concentrations did not differ
rom the overall MESA trial cohort. Men had a higher
iastolic blood pressure and LV mass compared with
omen, and were more likely to be current or former
mokers. Women had a higher body mass index and higher
holesterol levels (total, low-density lipoprotein, and high-
ensity lipoprotein cholesterol) than men.
RP and participant characteristics. Median CRP con-
entrations in men were 1.3 mg/l (IQR 0.7 to 3.0 mg/l), and
n women 2.6 mg/l (IQR 1.2 to 5.7 mg/l, p  0.001).
mong women but not men, CRP was significantly lower
mong those receiving lipid-lowering therapy compared
ith nonusers (2.1 mg/l [IQR 0.6 to 3.0 mg/l] vs. 2.7 mg/l
IQR 1.3 to 5.9 mg/l], p  0.02). A total of 27% of the
omen included in the cohort were current users of hor-
one replacement therapy. Women who were currently
sing hormone replacement therapy had significantly higher
RP levels compared with former or never-treated women
3.5 mg/l [IQR 1.8 to 6.7 mg/l] vs. 2.3 mg/l [IQR 1.1 to 4.9
g/l], p  0.0004). In both genders, current cigarette
mokers had higher CRP levels than former smokers or
ersons who had never smoked (p  0.001).
Finally, there was a positive relationship between LV
ass and log-CRP in women (regression coefficient 4.5 g
V mass per 1 unit higher log-CRP [mg/l], 95% confidence
nterval [CI] 2.4 to 6.5, p  0.001) and in men (regression
oefficient 5.0 g LV mass per 1 unit higher log-CRP [mg/l],
5% CI 2.0 to 8.0, p  0.001). This relationship remained
ignificant after multivariate adjustment for demographic
haracteristics and risk factors.
elationships between log-CRP and regional LV func-
ion. Because of a significant gender interaction, results are
hown separately for men and women. The unadjusted
ssociations of CRP and regional LV function for men and
omen are shown in Figure 1. In addition, these relation-
hips are shown as regression coefficients in Table 2. A
ositive regression coefficient indicates an association be-
ween higher log-CRP and lower absolute Ecc values, i.e.,
educed regional LV function. Higher log-CRP was asso-
iated with lower regional LV function in all regions in men
ut not in women (Fig. 1, Table 2).
In men, after adjustment for age, ethnicity, and tradi-
ional risk factors, the relationship between log-CRP and
ower regional LV function was attenuated slightly for
ifferent regions (Table 3, models I and II). Similar results
ere seen when waist circumference was substituted by body
ass index in the regression model. However, after further
djustment for LV mass, the relationship between log-CRP
nd Ecc weakened and remained statistically significant only mn the LAD territory (Table 3, model III). In contrast, the
esults were not markedly changed after adjusting for
oronary calcium scores in the corresponding regions (data
ot shown).
In women, in addition to the other covariates, hormone
eplacement therapy use was added to the regression model.
owever, no associations between log-CRP and regional
cc values were observed (Table 3). Results remained
nchanged after including LV mass in the regression model.
iscussion
he main finding of this study is that higher CRP concen-
ration is related to lower regional LV function determined
y Ecc in men, but not in women without evident heart
ailure or CAD in the MESA trial. This association was
nly modestly attenuated with adjustment for demographic
arameters and risk factors. Additional adjustment for LV
Figure 1 Peak Regional Systolic Ecc (%) by
CRP Quartiles (mg/l) in Men and Women
(A) Mean  SE error bars of peak systolic circumferential strain (Ecc) in the
left anterior descending artery (LAD), left circumflex artery (LCX), and right coro-
nary artery (RCA) regions are shown. Open bars, dotted bars, ruled bars, and
solid bars indicate 1st, 2nd, 3rd, and 4th quartiles of C-reactive protein (CRP)
levels, respectively. (B) Simple linear regression was used to determine the
trend. The p values indicate significance levels. By convention, systolic Ecc is
normally negative because of circumferential shortening. Therefore, lower
(absolute) values of Ecc reflect decreased regional function.ass measured by MRI weakened this relationship.
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Association Between CRP and LV Function February 6, 2007:594–600Inflammatory markers including CRP are associated with
n increased risk for cardiovascular morbidity and mortality
n asymptomatic men and women, and in patients with
cute coronary syndromes (1,4–6,8,17,18). Furthermore, in
he Health ABC study, among major cardiovascular events,
RP was most closely correlated with risk of future CHF (11).
ur findings document the association between CRP and LV
ysfunction among subjects without clinical heart failure or
oronary disease. In contrast to our study, gender interactions
ere not observed in previous studies of clinical outcomes.
We hypothesize that the presence of subclinical athero-
clerosis, endothelial dysfunction, and LV hypertrophy
ight underlie the association between CRP and regional
V dysfunction. These mechanisms are probably not mu-
ually exclusive, and each may contribute substantially to the
elationship between CRP and regional LV dysfunction.
Inflammation plays an important role in the development
nd progression of atherosclerosis. In the early stages of
therogenesis, local inflammatory stimuli including oxidized
ow-density lipoprotein lead to cytokine production
1,2,19). These cytokines in turn induce endothelial adhe-
ion and migration of monocytes into the lesion area,
roducing early atherosclerotic lesions. The CRP seems to
lay a role in this process by facilitating the activation of
Relationship Between Regional Ecc and Log-CR
Table 2 Relationship Between Regional Ecc
Region
Men
Regression Coefficient 95% CI p
LAD 0.45 0.17–0.72
LCX 0.39 0.08–0.71
RCA 0.35 0.06–0.63
Global Ecc 0.38 0.13–0.63
Relationship is expressed as a regression coefficient (unadjusted). Re
(mg/l). A positive value indicates an association of higher CRP with
regression coefficients for changes in regional strain for each gender.
CI  confidence interval; CRP  C-reactive protein; Ecc  circumfe
artery; LV  left ventricular; RCA  right coronary artery.
elationship Between Regional Ecc and Log-CRP in Men and in Woar meters; D mographic Parameters and Risk Factors; Dem
Table 3 Relationship Between Regional Ecc and Log-CRP in MParameters; Demographic Parameters and Risk Factor
Region
I
Regression Coefficient p Value Regres
Men
LAD 0.44 (0.15–0.72) 0.002 0.3
LCX 0.37 (0.05–0.69) 0.022 0.3
RCA 0.34 (0.05–0.62) 0.020 0.3
Global Ecc 0.37 (0.12–0.63) 0.004 0.3
Women
LAD 0.10 (0.25–0.46) 0.57 0.1
LCX 0.05 (0.48–0.37) 0.80 0.2
RCA 0.13 (0.48–0.21) 0.45 0.2
Global Ecc 0.04 (0.38–0.30) 0.80 0.0
egression coefficients are the differences in Ecc (%) per 1-U higher log-CRP (mg/l). A positive valu
onfidence intervals. The p values indicate significance levels of the regression coefficients for chang
isk factors (model II) include history of hypertension, antihypertensive medication, cholesterol, an
ormone replacement therapy status (current users vs. nonusers) was also included. Model III includes d
Abbreviations as in Table 2.nflammatory cells and enhancing cytokine production.
urthermore, the inflammatory process is associated with
laque weakening, rupture, and thrombus formation (1–4).
hus, it is logical to think that the relationship between
RP and regional LV dysfunction may be related to the
ssociation of CRP with these inflammatory processes
nown to promote local atherosclerosis. In this regard, it is
mportant to mention that the relationship between CRP
nd regional LV function was not modulated by coronary
alcium score.
This process may or not be associated with small regions
f myocardial infarction or scar tissue, even in the absence of
picardial CAD, possibly because of local thrombosis or
mbolism. These areas can be detected using delayed
ontrast hyperenhancement (20,21). Indeed, scars indicative
f unrecognized myocardial infarctions have been detected
y delayed hyperenhancement in a considerable number
20%) of elderly individuals participating in a community-
ased study in Sweden (22). Unfortunately, this technique
as not been used in the MESA trial, and this plausible
xplanation could not be studied.
Additionally, CRP may be related to incipient myocardial
ysfunction through its well-established association with
en and Women
Log-CRP in Men and Women
Women
Regression Coefficient 95% CI p Value
0.09 0.27–0.44 0.6
0.08 0.5–0.34 0.7
0.13 0.47–0.21 0.5
0.06 0.40–0.27 0.7
n coefficients are the differences in Ecc (%) per 1 U higher log-CRP
sed LV function. The p values indicate the significance levels of the
strain; LAD  left anterior descending artery; LCX  left circumflex
After Adjustment for Demographicic Parameters, Risk Fact rs, and LV Mass
d in Women After Adjustment for Demographic
d Demographic Parameters, Risk Factors, and LV Mass
II III
oefficient p Value Regression Coefficient p Value
–0.65) 0.01 0.31 (0.01–0.61) 0.04
01–0.64) 0.06 0.32 (0.03–0.66) 0.07
–0.59) 0.04 0.18 (0.12–0.49) 0.23
–0.58) 0.02 0.26 (0.01–0.53) 0.06
44–0.76) 0.60 0.24 (0.36–0.86) 0.42
90–0.49) 0.57 0.20 (0.92–0.52) 0.59
77–0.36) 0.49 0.27 (0.85–0.31) 0.36
65–0.48) 0.76 0.06 (0.64–0.52) 0.84
ates an association of higher CRP with LV dysfunction. The numbers in parentheses indicate 95%
gional strains. Demographic parameters (model I) include age, ethnicity, and waist circumference.
lipidemic medication, smoking status, and history of diabetes mellitus. In women, adjustment forP in M
and
Value
0.002
0.014
0.016
0.003
gressio
decreamengraph
en an
s; an
sion C
7 (0.08
2 (0.
1 (0.02
2 (0.05
6 (0.
0 (0.
0 (0.
9 (0.
e indic
es in re
tihyperemographic parameters (I), risk factors (II), and LV mass.
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February 6, 2007:594–600 Association Between CRP and LV Functionndothelial dysfunction. The CRP may directly alter endo-
helial function by reducing local production of nitric oxide,
r indirectly by increasing levels of reactive oxygen species,
hus reducing endothelial induced vasodilation (2,23–26).
A third possible mechanism pertains to the association
etween CRP and LV mass. We observed a significant
ssociation between CRP and LV mass. This relationship
as been shown previously in patients with hypertension
nd renal failure (27,28). It has been previously shown that
oncentric LV hypertrophy is related to decreased myocar-
ial function (29–32). In the current study, after adjustment
or LV mass, the association of higher CRP concentrations
nd reduced myocardial strain (Ecc) was attenuated, sug-
esting that the relationship between CRP and regional LV
unction might be linked to the association between CRP
nd LV mass.
An unexpected finding of this study was the gender
ifference in the association of CRP and regional LV
ysfunction. In men but not women, higher CRP was
ignificantly associated with regional LV dysfunction. Sub-
tantial gender differences in the presence of risk factors,
hown in Table 1, may partly explain this difference, but the
ender difference remained after controlling for those vari-
bles. It is theoretically possible, but unlikely, that women
ith elevated CRP and reduced regional LV function
eveloped symptoms earlier than men, and were therefore
xcluded from the MESA trial. A third and more plausible
xplanation is that gender-specific differences in the associ-
tion between CRP and regional LV function are modu-
ated through gender-related differences in LV mass. Pre-
ious studies have described gender-specific differences in
V remodeling and the development of LV dysfunction and
HF (33–38). The association between CRP levels and LV
ass and the gender-specific differences in the CRP/
egional dysfunction relationship fit this finding of gender
ifferences in the cardiac remodeling process. In contrast,
he Cardiovascular Health Study and the Health ABC
nvestigators reported a significant association between
igher CRP levels and the incidence of CHF in both
enders (11,39). These discrepancies suggest that in older
ndividuals, gender-related differences in the CRP LV
ysfunction relationships might disappear as women catch
p with men in the degree of atherosclerosis and inflammation.
owever, this possibility should be further explored.
Finally, the finding of regional differences in the associ-
tion between CRP and Ecc is noteworthy. The relation-
hip between CRP and regional function in the LAD and
CA seems to be stronger than in the LCX territory. This
ay be attributable to statistical power, because the varia-
ion in the LCX has been found to be slightly greater than
n other regions, probably because of a decreased signal-to-
oise ratio in the posterior wall. In addition, in a different
tudy, we have shown a greater coronary artery calcium score
nd a higher extent of significant CAD in the LAD region
ompared with other regions (unpublished data). Further
tudies should be performed to clarify these findings.
jethodological considerations. Our study includes 1,164
ubjects, making this one of the largest MRI studies of
uantitative regional myocardial function that we are aware
f. The HARP software is a robust analytical tool that
llows for efficient and reliable determinations of regional
V function by MRI tagging (13,15). Aside from its size,
he MESA trial entails a heterogeneous population from
ifferent ethnicities.
On the other hand, the cross-sectional study design
mpairs the ability to establish the temporal nature of the
ssociation. Participants were selected to participate in the
ESA trial through a population-based process designed to
inimize biases typically associated with studies of volun-
eers. However, they may not represent a random sample of
he population. In addition, excluding symptomatic patients
ould have affected the results of this study, as discussed
arlier.
Temporal resolution is an important determinant of the
uality of strain measurement. In the present study, the
ean temporal resolution was 40 ms. This temporal reso-
ution is lower than the resolution that can be achieved by
chocardiography (i.e., 7 to 10 ms). However, MRI is not
imited by acoustic windows and scanning angles and can
rovide a detailed strain map of the entire myocardium. In
ddition, a previous study has shown a high correlation
etween strain values measured by echocardiography and
agged MRI (40).
Finally, except for a small study that measured only for
egional myocardial perfusion, contrast-enhanced MR im-
ges were not acquired routinely in the MESA trial.
herefore, we could not address the possibility that areas
ith reduced regional function may indeed reflect silent in-
racted regions manifesting as a delayed enhancement pattern.
In conclusion, we document an inverse relationship be-
ween CRP levels and regional LV function in men. This
ssociation was seen in all regions and did not change after
djusting for age, traditional risk factors, or medical treat-
ent. In contrast, such a relationship was not evident in
omen. The association between CRP and LV function
as attenuated by adjustment for LV mass. Further studies
re warranted to elucidate the interrelationship between
nflammation, LV mass, and gender in the development of
V dysfunction and heart failure.
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